HEADER HYDROLASE 09-JAN-12 3VFD TITLE HUMAN SPASTIN AAA DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPASTIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: AAA DOMAIN; COMPND 5 SYNONYM: SPASTIC PARAPLEGIA 4 PROTEIN; COMPND 6 EC: 3.6.4.3; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADPSP, FSP2, KIAA1083, SPAST, SPG4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-3 KEYWDS ATPASE, MICROTUBULE SEVERING, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.L.TAYLOR,S.R.WHITE,B.LAURING,F.J.KULL REVDAT 4 13-SEP-23 3VFD 1 REMARK REVDAT 3 15-NOV-17 3VFD 1 REMARK REVDAT 2 09-JAN-13 3VFD 1 JRNL REVDAT 1 30-MAY-12 3VFD 0 JRNL AUTH J.L.TAYLOR,S.R.WHITE,B.LAURING,F.J.KULL JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN SPASTIN AAA DOMAIN. JRNL REF J.STRUCT.BIOL. V. 179 133 2012 JRNL REFN ISSN 1047-8477 JRNL PMID 22446388 JRNL DOI 10.1016/J.JSB.2012.03.002 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.1_743) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.25 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 5983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.910 REMARK 3 FREE R VALUE TEST SET COUNT : 593 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.2540 - 5.2381 1.00 1365 151 0.2106 0.2713 REMARK 3 2 5.2381 - 4.1586 1.00 1355 151 0.1921 0.2514 REMARK 3 3 4.1586 - 3.6333 1.00 1347 145 0.1951 0.2825 REMARK 3 4 3.6333 - 3.3012 1.00 1323 146 0.2392 0.3217 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 49.11 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 1.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.910 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.87360 REMARK 3 B22 (A**2) : 5.87360 REMARK 3 B33 (A**2) : -11.74720 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2091 REMARK 3 ANGLE : 1.184 2816 REMARK 3 CHIRALITY : 0.078 331 REMARK 3 PLANARITY : 0.005 363 REMARK 3 DIHEDRAL : 15.239 800 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3VFD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000069975. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9775 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5983 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 44.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 11.30 REMARK 200 R MERGE (I) : 0.11600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 11.10 REMARK 200 R MERGE FOR SHELL (I) : 0.59800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX AUTOMR REMARK 200 STARTING MODEL: PDB ENTRY 3B9P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6M (NH3)2SO4, 0.1M MES MONOHYDRATE REMARK 280 (PH 6.5),10% 1,4-DIOXANE AND 4% BENZAMIDINE HCL, 1MM ATP, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.06667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.53333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 44.30000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 14.76667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 73.83333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 228 REMARK 465 SER A 229 REMARK 465 GLY A 230 REMARK 465 ALA A 231 REMARK 465 VAL A 232 REMARK 465 PRO A 233 REMARK 465 LYS A 234 REMARK 465 ARG A 235 REMARK 465 LYS A 236 REMARK 465 ASP A 237 REMARK 465 PRO A 238 REMARK 465 LEU A 239 REMARK 465 THR A 240 REMARK 465 HIS A 241 REMARK 465 THR A 242 REMARK 465 SER A 243 REMARK 465 ASN A 244 REMARK 465 SER A 245 REMARK 465 LEU A 246 REMARK 465 PRO A 247 REMARK 465 ARG A 248 REMARK 465 SER A 249 REMARK 465 LYS A 250 REMARK 465 THR A 251 REMARK 465 VAL A 252 REMARK 465 MET A 253 REMARK 465 LYS A 254 REMARK 465 THR A 255 REMARK 465 GLY A 256 REMARK 465 SER A 257 REMARK 465 ALA A 258 REMARK 465 GLY A 259 REMARK 465 LEU A 260 REMARK 465 SER A 261 REMARK 465 GLY A 262 REMARK 465 HIS A 263 REMARK 465 HIS A 264 REMARK 465 ARG A 265 REMARK 465 ALA A 266 REMARK 465 PRO A 267 REMARK 465 SER A 268 REMARK 465 TYR A 269 REMARK 465 SER A 270 REMARK 465 GLY A 271 REMARK 465 LEU A 272 REMARK 465 SER A 273 REMARK 465 MET A 274 REMARK 465 VAL A 275 REMARK 465 SER A 276 REMARK 465 GLY A 277 REMARK 465 VAL A 278 REMARK 465 LYS A 279 REMARK 465 GLN A 280 REMARK 465 GLY A 281 REMARK 465 SER A 282 REMARK 465 GLY A 283 REMARK 465 PRO A 284 REMARK 465 ALA A 285 REMARK 465 PRO A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 HIS A 289 REMARK 465 LYS A 290 REMARK 465 GLY A 291 REMARK 465 THR A 292 REMARK 465 PRO A 293 REMARK 465 LYS A 294 REMARK 465 THR A 295 REMARK 465 ASN A 296 REMARK 465 ARG A 297 REMARK 465 THR A 298 REMARK 465 ASN A 299 REMARK 465 LYS A 300 REMARK 465 PRO A 301 REMARK 465 SER A 302 REMARK 465 THR A 303 REMARK 465 PRO A 304 REMARK 465 THR A 305 REMARK 465 THR A 306 REMARK 465 ALA A 307 REMARK 465 THR A 308 REMARK 465 ARG A 309 REMARK 465 LYS A 310 REMARK 465 LYS A 311 REMARK 465 LYS A 312 REMARK 465 ASP A 313 REMARK 465 LEU A 314 REMARK 465 LYS A 315 REMARK 465 ASN A 316 REMARK 465 PHE A 317 REMARK 465 ARG A 318 REMARK 465 ASN A 319 REMARK 465 VAL A 320 REMARK 465 ASP A 321 REMARK 465 SER A 322 REMARK 465 ASN A 323 REMARK 465 THR A 412 REMARK 465 SER A 413 REMARK 465 LYS A 414 REMARK 465 TYR A 415 REMARK 465 VAL A 416 REMARK 465 GLY A 417 REMARK 465 GLU A 418 REMARK 465 CYS A 448 REMARK 465 GLU A 449 REMARK 465 ARG A 450 REMARK 465 ARG A 451 REMARK 465 GLU A 452 REMARK 465 GLY A 453 REMARK 465 GLU A 454 REMARK 465 HIS A 455 REMARK 465 SER A 475 REMARK 465 ALA A 476 REMARK 465 GLY A 477 REMARK 465 ASP A 478 REMARK 465 ASP A 479 REMARK 465 GLN A 569 REMARK 465 VAL A 570 REMARK 465 LYS A 571 REMARK 465 ASP A 614 REMARK 465 THR A 615 REMARK 465 THR A 616 REMARK 465 VAL A 617 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 411 CG CD1 CD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 421 CB CG CD CE NZ REMARK 480 ARG A 459 CB CG CD NE CZ NH1 NH2 REMARK 480 LYS A 462 CB CG CD CE NZ REMARK 480 LYS A 591 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 523 O GLY A 527 2.15 REMARK 500 NH1 ARG A 364 OE2 GLU A 366 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 335 -63.61 -95.73 REMARK 500 GLN A 347 65.10 62.35 REMARK 500 ARG A 364 68.40 -118.78 REMARK 500 ALA A 408 -138.67 58.16 REMARK 500 ASN A 511 -179.82 -69.43 REMARK 500 LYS A 566 157.51 67.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 433 GLN A 434 -144.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 701 DBREF 3VFD A 228 617 UNP Q9UBP0 SPAST_HUMAN 228 616 SEQADV 3VFD GLN A 442 UNP Q9UBP0 GLU 442 ENGINEERED MUTATION SEQRES 1 A 389 GLU SER GLY ALA VAL PRO LYS ARG LYS ASP PRO LEU THR SEQRES 2 A 389 HIS THR SER ASN SER LEU PRO ARG SER LYS THR VAL MET SEQRES 3 A 389 LYS THR GLY SER ALA GLY LEU SER GLY HIS HIS ARG ALA SEQRES 4 A 389 PRO SER TYR SER GLY LEU SER MET VAL SER GLY VAL LYS SEQRES 5 A 389 GLN GLY SER GLY PRO ALA PRO THR THR HIS LYS GLY THR SEQRES 6 A 389 PRO LYS THR ASN ARG THR ASN LYS PRO SER THR PRO THR SEQRES 7 A 389 THR ALA THR ARG LYS LYS LYS ASP LEU LYS ASN PHE ARG SEQRES 8 A 389 ASN VAL ASP SER ASN LEU ALA ASN LEU ILE MET ASN GLU SEQRES 9 A 389 ILE VAL ASP ASN GLY THR ALA VAL LYS PHE ASP ASP ILE SEQRES 10 A 389 ALA GLY GLN ASP LEU ALA LYS GLN ALA LEU GLN GLU ILE SEQRES 11 A 389 VAL ILE LEU PRO SER LEU ARG PRO GLU LEU PHE THR GLY SEQRES 12 A 389 LEU ARG ALA PRO ALA ARG GLY LEU LEU LEU PHE GLY PRO SEQRES 13 A 389 PRO GLY ASN GLY LYS THR MET LEU ALA LYS ALA VAL ALA SEQRES 14 A 389 ALA GLU SER ASN ALA THR PHE PHE ASN ILE SER ALA ALA SEQRES 15 A 389 SER LEU THR SER LYS TYR VAL GLY GLU GLY GLU LYS LEU SEQRES 16 A 389 VAL ARG ALA LEU PHE ALA VAL ALA ARG GLU LEU GLN PRO SEQRES 17 A 389 SER ILE ILE PHE ILE ASP GLN VAL ASP SER LEU LEU CYS SEQRES 18 A 389 GLU ARG ARG GLU GLY GLU HIS ASP ALA SER ARG ARG LEU SEQRES 19 A 389 LYS THR GLU PHE LEU ILE GLU PHE ASP GLY VAL GLN SER SEQRES 20 A 389 ALA GLY ASP ASP ARG VAL LEU VAL MET GLY ALA THR ASN SEQRES 21 A 389 ARG PRO GLN GLU LEU ASP GLU ALA VAL LEU ARG ARG PHE SEQRES 22 A 389 ILE LYS ARG VAL TYR VAL SER LEU PRO ASN GLU GLU THR SEQRES 23 A 389 ARG LEU LEU LEU LEU LYS ASN LEU LEU CYS LYS GLN GLY SEQRES 24 A 389 SER PRO LEU THR GLN LYS GLU LEU ALA GLN LEU ALA ARG SEQRES 25 A 389 MET THR ASP GLY TYR SER GLY SER ASP LEU THR ALA LEU SEQRES 26 A 389 ALA LYS ASP ALA ALA LEU GLY PRO ILE ARG GLU LEU LYS SEQRES 27 A 389 PRO GLU GLN VAL LYS ASN MET SER ALA SER GLU MET ARG SEQRES 28 A 389 ASN ILE ARG LEU SER ASP PHE THR GLU SER LEU LYS LYS SEQRES 29 A 389 ILE LYS ARG SER VAL SER PRO GLN THR LEU GLU ALA TYR SEQRES 30 A 389 ILE ARG TRP ASN LYS ASP PHE GLY ASP THR THR VAL HET SO4 A 701 5 HETNAM SO4 SULFATE ION FORMUL 2 SO4 O4 S 2- HELIX 1 1 LEU A 327 GLU A 331 5 5 HELIX 2 2 LYS A 340 ILE A 344 5 5 HELIX 3 3 GLN A 347 VAL A 358 1 12 HELIX 4 4 VAL A 358 ARG A 364 1 7 HELIX 5 5 THR A 369 ALA A 373 5 5 HELIX 6 6 GLY A 387 SER A 399 1 13 HELIX 7 7 GLU A 420 LEU A 433 1 14 HELIX 8 8 VAL A 443 LEU A 447 5 5 HELIX 9 9 ALA A 457 GLN A 473 1 17 HELIX 10 10 ARG A 489 LEU A 493 5 5 HELIX 11 11 ASP A 494 ARG A 499 1 6 HELIX 12 12 ASN A 511 CYS A 524 1 14 HELIX 13 13 THR A 531 THR A 542 1 12 HELIX 14 14 SER A 546 ALA A 558 1 13 HELIX 15 15 LEU A 559 GLU A 564 1 6 HELIX 16 16 ARG A 582 ILE A 593 1 12 HELIX 17 17 SER A 598 PHE A 612 1 15 SHEET 1 A 5 THR A 402 ILE A 406 0 SHEET 2 A 5 SER A 436 ASP A 441 1 O PHE A 439 N PHE A 404 SHEET 3 A 5 VAL A 481 THR A 487 1 O LEU A 482 N ILE A 438 SHEET 4 A 5 GLY A 377 PHE A 381 1 N LEU A 380 O GLY A 485 SHEET 5 A 5 LYS A 503 TYR A 506 1 O VAL A 505 N PHE A 381 CISPEP 1 MET A 573 SER A 574 0 9.15 SITE 1 AC1 6 PRO A 383 GLY A 385 ASN A 386 GLY A 387 SITE 2 AC1 6 LYS A 388 THR A 389 CRYST1 88.500 88.500 88.600 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011299 0.006524 0.000000 0.00000 SCALE2 0.000000 0.013047 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011287 0.00000